Georgios Papanikolaou

From WikiMD's WELLNESSPEDIA

Georgios Papanikolaou (or George Papanicolaou; May 13, 1883 – February 19, 1962) was a Greek physician, biologist, and cytologist who is best known for inventing the Pap smear, a method of detecting cervical cancer.

Early life and education[edit]

Papanikolaou was born on May 13, 1883, in Kymi, Euboea, Greece. He studied at the University of Athens where he received his medical degree in 1904. He then went on to study at the University of Munich, where he received his PhD in Zoology in 1910.

Career[edit]

After completing his studies, Papanikolaou worked in the military as a doctor during the Balkan Wars. In 1913, he moved to the United States and began working at the New York Hospital and the Cornell University Medical College.

In 1928, Papanikolaou developed the Pap smear, a test that could detect early signs of cervical cancer and uterine cancer. This test has since become a standard procedure in gynecology and has saved countless lives.

Papanikolaou also made significant contributions to the understanding of the menstrual cycle, discovering that it could be tracked through changes in the vaginal smear.

Legacy[edit]

Papanikolaou's work has had a profound impact on women's health, with the Pap smear being a crucial tool in the early detection and prevention of cervical cancer. His contributions to medicine have been recognized by numerous awards and honors, including the Lasker Award in 1950.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.